Wellborn Pharmaceuticals Private Limited
About Wellborn Pharmaceuticals Private Limited
Data last updated:
Wellborn Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 19 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2012PTC242504. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shyam Kishor Sahay and Rakesh Kumar Sinha.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at 430 A Sant Nagar East Of Kailash, New Delhi, Delhi, India – 110067.
As per the financials filed for FY 2018, the company reported a revenue of ₹8.44 Lakh, a decline of 43% compared to the previous year. For the same year it recorded a net loss of ₹14,358 (net margin -1.7%) and EBITDA of ₹52,409 (EBITDA margin 6.2%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
As per MCA filings, the company has open charges of ₹8 Lakh on record.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address430 A Sant Nagar East Of Kailash, New Delhi, Delhi, India – 110067
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wellborn Pharmaceuticals Private Limited
The main business activity of Wellborn Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wellborn Pharmaceuticals Private Limited FY 2018 filings available
Wellborn Pharmaceuticals Private Limited reported revenue of ₹8.44 Lakh (down 43% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR) of Wellborn Pharmaceuticals Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 43% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wellborn Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹52,409 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹14,358 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Wellborn Pharmaceuticals Private Limited
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 6.2% | •••• | •••• | •••• |
| Net Profit Margin | -1.7% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wellborn Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Wellborn Pharmaceuticals Private Limited
Wellborn Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shyam Kishor Sahay | Director | 19 Sep 2012 | 14 Years 1 Months | Current |
| Rakesh Kumar Sinha | Director | 19 Sep 2012 | 14 Years 1 Months | Current |
Peer Comparison of Wellborn Pharmaceuticals Private Limited
Wellborn Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nidedak Pharmaceuticals Private Limited | ₹8.51 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Allahabad, Uttar Pradesh, India |
| Hyssop Pharmaceuticals Private Limited | ₹8.5 Lakh (FY 2024) | •••• | •••• | -55.0% | •••• | Ranchi, Jharkhand, India |
| Ip Pharmaceuticals India Private Limited | ₹8.49 Lakh (FY 2021) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Endospy Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2025) | •••• | •••• | 70.0% | •••• | Pune, Maharashtra, India |
| Trans Pharmaceuticals Private Limited | ₹8.48 Lakh (FY 2021) | •••• | •••• | -85.0% | •••• | Ahmednagar, Maharashtra, India |
| Wellborn Pharmaceuticals Private Limited this company | ₹8.44 Lakh (FY 2018) | •••• | •••• | -43.0% | •••• | New Delhi, Delhi, India |
| Kon Pharmaceuticals Trading Private Limited | ₹8.43 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Burdwan, West Bengal, India |
| Vagmin Pharmaceuticals Private Limited | ₹8.43 Lakh (FY 2019) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Bhati Pharmaceuticals (OPC) Private Limited | ₹8.42 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Raipur, Chhattisgarh, India |
| Vilkem Pharmaceuticals (OPC) Private Limited | ₹8.4 Lakh (FY 2025) | •••• | •••• | -5.0% | •••• | Mumbai, Maharashtra, India |
| Eyechem Pharmaceuticals Private Limited | ₹8.39 Lakh (FY 2024) | •••• | •••• | •••• | Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Wellborn Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Wellborn Pharmaceuticals Private Limited
Wellborn Pharmaceuticals Private Limited is audited by BNKedia& Company for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| BNKedia& Company | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Wellborn Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wellborn Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jun 2014 | Others | ₹8 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Wellborn Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Wellborn Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wellborn Pharmaceuticals Private Limited
Wellborn Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Rakesh Kumar Sinha was appointed as Director on 19 Sep 2012.
Credit Ratings, Litigation & Regulatory Alerts for Wellborn Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wellborn Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wellborn Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wellborn Pharmaceuticals Private Limited
Wellborn Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wellborn Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wellborn Pharmaceuticals Private Limited
Wellborn Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in wholesale, within the trading industry. It was incorporated on 19 September 2012 (14+ years old) and is registered under CIN U51909DL2012PTC242504.
Wellborn Pharmaceuticals reported revenue of ₹8.44 Lakh for FY 2018 (down 43% YoY).
Wellborn Pharmaceuticals has 2 current directors:
- Shyam Kishor Sahay - Director
- Rakesh Kumar Sinha - Director
Wellborn Pharmaceuticals reported a net loss of ₹14,358 (net margin -1.7%) and EBITDA of ₹52,409 (EBITDA margin 6.2%) for FY 2018, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wellborn Pharmaceuticals is -7% over three years. In the latest year (FY 2018) revenue fell 43%. CAGR is the steady yearly rate that links the first and the last year.
No. Wellborn Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Wellborn Pharmaceuticals is U51909DL2012PTC242504. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellborn Pharmaceuticals was incorporated on 19 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Wellborn Pharmaceuticals by revenue are Nidedak Pharmaceuticals Private Limited, Hyssop Pharmaceuticals Private Limited, Ip Pharmaceuticals India Private Limited, Endospy Pharmaceuticals Private Limited, Trans Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Rakesh Kumar Sinha was appointed as Director on 19 Sep 2012. Shyam Kishor Sahay was appointed as Director on 19 Sep 2012.
The registered office of Wellborn Pharmaceuticals is at 430 A Sant Nagar East Of Kailash, New Delhi, Delhi, India – 110067.